Darvin J. Griffin, PhD

Darvin J. Griffin, PhD is a medical research and development leader who currently serves as the Director of Clinical Development at AbbVie, a biopharmaceutical company.12

Education and Early Career

Griffin earned his undergraduate degree in biological engineering from Mississippi State University's Bagley College of Engineering.3 He then went on to pursue graduate studies at Cornell University, where he obtained both his M.S. and Ph.D. degrees.1

During his time at Cornell, Griffin focused his research on orthopedics and articular repair. He collaborated with entities such as Genzyme, Histogenics, and Massachusetts General Hospital while building his portfolio in this field.4

Professional Experience

After completing his doctorate in 2015, Griffin entered the medical device sector, where he has continued to develop his career in clinical research.1 His current role at AbbVie involves:

• Developing and implementing global clinical development strategies
• Focusing on next-generation aesthetic devices
• Leading efforts in the Allergan Aesthetics division of AbbVie1

Recognition

In 2022, Griffin was recognized by Mississippi State University's Bagley College of Engineering as the recipient of their Emerging Leader award.1 This award acknowledges alumni under 40 who have already made significant impacts in their profession or community.1

Griffin's career trajectory demonstrates his commitment to advancing medical research and development, particularly in the areas of aesthetics and medical devices. His educational background in biomedical engineering, combined with his industry experience, has positioned him as a leader in clinical development within the pharmaceutical and medical device sectors.